INSM
Price
$71.96
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
2 days until earnings call
SRPT
Price
$130.26
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
Ad is loading...

INSM vs SRPT

Header iconINSM vs SRPT Comparison
Open Charts INSM vs SRPTBanner chart's image
Insmed
Price$71.96
Change-$0.00 (-0.00%)
Volume$1.28M
CapitalizationN/A
Sarepta Therapeutics
Price$130.26
Change-$0.00 (-0.00%)
Volume$515.93K
CapitalizationN/A
View a ticker or compare two or three
INSM vs SRPT Comparison Chart
Loading...
INSM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
INSM vs. SRPT commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSM is a StrongBuy and SRPT is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (INSM: $71.96 vs. SRPT: $130.26)
Brand notoriety: INSM: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INSM: 85% vs. SRPT: 66%
Market capitalization -- INSM: $12.46B vs. SRPT: $11.88B
INSM [@Biotechnology] is valued at $12.46B. SRPT’s [@Biotechnology] market capitalization is $11.88B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSM’s FA Score shows that 1 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • INSM’s FA Score: 1 green, 4 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, INSM is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSM’s TA Score shows that 2 TA indicator(s) are bullish while SRPT’s TA Score has 5 bullish TA indicator(s).

  • INSM’s TA Score: 2 bullish, 7 bearish.
  • SRPT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than INSM.

Price Growth

INSM (@Biotechnology) experienced а -0.44% price change this week, while SRPT (@Biotechnology) price change was +2.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

INSM is expected to report earnings on Feb 20, 2025.

SRPT is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($12.5B) and SRPT($11.9B) have the same market capitalization . INSM YTD gains are higher at: 132.204 vs. SRPT (35.082). SRPT has higher annual earnings (EBITDA): 121M vs. INSM (-709.62M). SRPT has more cash in the bank: 1.46B vs. INSM (1.25B). INSM has less debt than SRPT: INSM (1.22B) vs SRPT (1.37B). SRPT has higher revenues than INSM: SRPT (1.51B) vs INSM (329M).
INSMSRPTINSM / SRPT
Capitalization12.5B11.9B105%
EBITDA-709.62M121M-586%
Gain YTD132.20435.082377%
P/E RatioN/A166.52-
Revenue329M1.51B22%
Total Cash1.25B1.46B85%
Total Debt1.22B1.37B89%
FUNDAMENTALS RATINGS
INSM vs SRPT: Fundamental Ratings
INSM
SRPT
OUTLOOK RATING
1..100
728
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
1464
SMR RATING
1..100
10083
PRICE GROWTH RATING
1..100
3653
P/E GROWTH RATING
1..100
10092
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRPT's Valuation (88) in the Biotechnology industry is in the same range as INSM (99). This means that SRPT’s stock grew similarly to INSM’s over the last 12 months.

INSM's Profit vs Risk Rating (14) in the Biotechnology industry is somewhat better than the same rating for SRPT (64). This means that INSM’s stock grew somewhat faster than SRPT’s over the last 12 months.

SRPT's SMR Rating (83) in the Biotechnology industry is in the same range as INSM (100). This means that SRPT’s stock grew similarly to INSM’s over the last 12 months.

INSM's Price Growth Rating (36) in the Biotechnology industry is in the same range as SRPT (53). This means that INSM’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's P/E Growth Rating (92) in the Biotechnology industry is in the same range as INSM (100). This means that SRPT’s stock grew similarly to INSM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INSMSRPT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 16 days ago
73%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
73%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
72%
View a ticker or compare two or three
Ad is loading...
INSM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+1.41%
THAR - INSM
74%
Closely correlated
+1.54%
CALT - INSM
69%
Closely correlated
N/A
AGIO - INSM
44%
Loosely correlated
+2.20%
SRPT - INSM
44%
Loosely correlated
-0.67%
VERA - INSM
41%
Loosely correlated
+15.21%
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with GLMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then GLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
-0.67%
GLMD - SRPT
51%
Loosely correlated
-0.76%
ALZN - SRPT
49%
Loosely correlated
N/A
XBIO - SRPT
48%
Loosely correlated
+3.29%
RARE - SRPT
46%
Loosely correlated
-1.39%
BMRN - SRPT
45%
Loosely correlated
+0.59%
More